Facebook tracking pixel
K11.7
ICD-10-CM
Hypersalivation

Find comprehensive information on hypersalivation, including clinical documentation, medical coding, ICD-10 codes, diagnosis, treatment, causes, symptoms, and management of excessive salivation. Learn about sialorrhea, ptyalism, drooling, and their connection to neurological conditions, medications, and other medical issues. Explore resources for healthcare professionals on accurately documenting and coding hypersalivation for optimal patient care and reimbursement.

Also known as

Excessive drooling
Sialorrhea

Related ICD-10 Code Ranges

Complete code families applicable to AAPC K11.7 Coding
R30.2

Excessive salivation

Increased production of saliva.

K11.7

Sialoadenitis

Inflammation of the salivary glands, sometimes causing hypersalivation.

G40-G47

Epilepsy and seizures

Hypersalivation can be a symptom of certain seizure disorders.

R63.8

Other symptoms and signs

Hypersalivation may be coded here if not otherwise specified.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is hypersalivation due to a medication?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Excessive saliva production
Sialorrhea (same as hypersalivation)
Pseudo-hypersalivation

Documentation Best Practices

Documentation Checklist
  • Hypersalivation diagnosis: Document onset, duration, severity.
  • ICD-10 code R30.2: Drooling, excessive salivation noted.
  • Rule out medications, pregnancy as contributing factors.
  • Differentiate ptyalism from other oral conditions.
  • Assess impact on speech, swallowing, social interaction.

Mitigation Tips

Best Practices
  • ICD-10 R30.2, CDI: Document underlying cause, medication review.
  • SNOMED CT 302497002, rule out pregnancy, meds, neuro conditions.
  • Treat root cause: anticholinergics (caution, side effects).
  • Behavioral therapy: speech therapy, posture adjustments.
  • Oral hygiene, hydration for comfort, monitor for infections.

Clinical Decision Support

Checklist
  • Confirm excessive saliva objectively (volume/frequency)
  • Rule out other causes: medication, reflux, oral infection
  • Assess swallowing function: screen for dysphagia
  • Document impact on patient: speech, hygiene, QOL

Reimbursement and Quality Metrics

Impact Summary
  • Hypersalivation reimbursement impacts ICD-10 R30.2, CPT 42800-42821, impacting medical billing, coding accuracy, denials.
  • Quality metrics: Drooling frequency, oral hygiene complications, skin integrity issues affect hospital reporting, patient outcomes.
  • Coding accuracy crucial for appropriate reimbursement in sialorrhea cases. Impacts hospital revenue cycle management.
  • Proper documentation of hypersalivation etiology (e.g., medication side effect) key for accurate billing and coding.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective evidence-based management strategies for hypersalivation in neurologically impaired adult patients?

A: Managing hypersalivation, also known as sialorrhea, in neurologically impaired adults requires a multifaceted approach based on the underlying cause and severity. Evidence-based management strategies include non-pharmacological interventions such as speech therapy focusing on oral motor exercises and postural adjustments to improve swallowing and reduce drooling. Pharmacological interventions, including anticholinergic medications like glycopyrrolate and scopolamine, can be effective but require careful consideration of potential side effects like dry mouth, constipation, and cognitive impairment. Botulinum toxin injections into the salivary glands can also significantly reduce saliva production, offering a localized approach. The choice of treatment should be individualized based on patient-specific factors. Explore how a comprehensive assessment can guide personalized hypersalivation management. Consider implementing a combination of therapies for optimal outcomes.

Q: How can I differentiate between hypersalivation and pseudoptyalism in a patient presenting with excessive drooling and what diagnostic tests should I consider?

A: Differentiating between true hypersalivation (increased saliva production) and pseudoptyalism (impaired swallowing leading to the perception of excessive saliva) is crucial for effective management. Careful clinical evaluation should focus on observing swallowing function, oral motor control, and any associated neurological deficits. A detailed patient history, including medications, comorbidities, and the onset of symptoms, is essential. While no single diagnostic test definitively distinguishes between the two, videofluoroscopic swallow study (VFSS) can provide valuable insights into swallowing mechanics and identify any underlying oropharyngeal dysphagia contributing to pseudoptyalism. Sialometry, while less commonly used, can objectively measure saliva production rates. Learn more about the role of comprehensive assessment in differentiating hypersalivation from other swallowing disorders. Consider implementing a multidisciplinary approach involving speech-language pathologists and neurologists for accurate diagnosis and personalized treatment plans.

Quick Tips

Practical Coding Tips
  • Code primary cause of hypersalivation
  • Document symptom onset and severity
  • Consider R30.2 with underlying condition
  • Rule out medication-induced sialorrhea
  • Specify if ptyalism or drooling

Documentation Templates

Patient presents with a chief complaint of excessive salivation, also described as ptyalism or sialorrhea.  Onset of hypersalivation was noted (timeframe and context of onset, e.g., two weeks ago, gradually over several months, associated with a new medication).  The patient reports (frequency and severity of hypersalivation, e.g., constant drooling, intermittent episodes of excessive saliva production, interference with speech or swallowing).  Associated symptoms include (list any relevant symptoms, e.g., nausea, vomiting, dysphagia, heartburn, oral pain, sores, or lesions).  Medical history is significant for (list relevant medical conditions, e.g., GERD, Parkinson's disease, cerebral palsy, amyotrophic lateral sclerosis ALS, stroke, Bell's palsy, pregnancy).  Current medications include (list all current medications, including prescription, over-the-counter, and supplements).  Allergies include (list all allergies and reactions).  Physical examination reveals (describe relevant findings, e.g., pooling of saliva in the oral cavity, normal or abnormal tongue movements, presence of any oral lesions or abnormalities, neurological examination findings).  Differential diagnosis includes medication side effects, gastroesophageal reflux disease GERD, neurological disorders, oral infections, and pregnancy-related hypersalivation.  Assessment:  Hypersalivation likely secondary to (state suspected cause based on clinical findings, e.g., medication side effect, underlying neurological condition).  Plan:  (outline treatment plan, e.g., discontinue or adjust causative medication if applicable,  referral to specialist such as neurologist, gastroenterologist, or speech therapist,  consider anticholinergic medications for symptomatic management, oral hygiene recommendations).  Patient education provided regarding the potential causes of hypersalivation, management strategies, and follow-up care.  Follow-up scheduled in (timeframe) to assess response to treatment.